V-Wave
V Wave develops an implant for the treatment of congestive heart failure.
V-Wave has raised €80M across 2 funding rounds from 13 investors, most recently a Series C round in Sep 2020. Based in Caesarea, Israel; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€80M
€80,043,390
Funding rounds
2
Investors
13
distinct backers
Active since
2018-02
latest 2020-09
Funding by year
EUR raised per yearV-Wave — funding by year — interactive chart.
Data table
| V-Wave — funding by year | |
|---|---|
| 2018 | €56M |
| 2020 | €24M |
Signals
High confidenceRaise-next likelihood8
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (16y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-23 | Series C | €24M | Deerfield | View deal → |
| 2018-02-01 | Other | €56M | Aperture Capital,BioStar Ventures,BRM Capital,Deerfield,Edwards Lifesciences,Endeavour Vision+6 more | View deal → |
Investors
13Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData